Oral Dosage Forms of Catalase Associated with Probiotics Using Carboxymethylcellulose and Carboxymethylstarch: A Potential Approach for Intestinal Inflammation
Inflammatory bowel diseases frequently associated with oxidative stress phenomena represent an important component of intestinal inflammation. An excess of hydrogen peroxide (H2O2) is mucosa damaging, and its removal becomes a therapeutic strategy. The oral administration of antioxidant enzymes such as catalase remains challenging because enzyme activity can be rapidly impaired under gastric conditions. Carboxymethylcellulose (CMC)- and carboxymethylstarch (CMS)-based tablets for oral delivery of catalase were investigated. Tablets containing 30% (w/w) catalase were exposed for 2 h to simulated gastric fluid (SGF) followed by 5 h in simulated intestinal fluid (SIF). Approximately 58% of the initial catalase activity was recovered from the CMC-based tablets, and about 44% from the CMS-based tablets. Despite this partial recovery, both formulations retained sufficient functional activity to achieve near-complete degradation of 5 mM H2O2 in vitro within 240 min for CMC and 300 min for CMS. The incorporation of cross-linked starch improved the mechanical strength of the CMC-based tablets and maintained the percentage of catalase recovery. The association of catalase and probiotics within the same formulation was also examined. The co-formulated catalase–probiotics maintained bacterial viability following 2 h of gastric exposure and 5 h in SIF. The presence of catalase did not compromise the bacterial viability. It appears that such a system could provide a basis for future strategies simultaneously targeting intestinal oxidative stress and microbiota imbalance.
Authors
- Mircea Alexandru Mateescu (ORCID: https://orcid.org/0000-0001-5922-4701)
- Younès Chorfi (ORCID: https://orcid.org/0000-0001-7893-9649)
- Patrick Gosselin (ORCID: https://orcid.org/0009-0008-5814-1304)
- Armelle Tchoumi Nerée (ORCID: https://orcid.org/0000-0001-6518-7011)
- Al Hadji Malick Dieye (ORCID: https://orcid.org/0009-0009-1669-010X)
Institutions
- Université du Québec à Montréal (CA)
- Armand Frappier Museum (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/ijms272210358
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Mitacs
- Natural Sciences and Engineering Research Council of Canada